Novel Polio Vaccine Investments Offer Measurable Returns

In COVID-19, Latest News by Precision Vaccinations

A recent investment case has shown that a successful polio transition in the WHO Eastern Mediterranean Region can generate a high return on investment.
According to the study, sustaining and integrating polio assets into expanded immunization, surveillance, and emergency response programs can bring economic and social benefits worth an estimated $289.2 billion.
With the current cost of this work being $7.5 billion, it means that for every dollar spent, the return on investment is almost $39.

Read More